arch 31, 2013. Stockholders' equity totaled $438.8 million as of March 31, 2013, compared to $436.3 million at the end of 2012. Cash flow provided by operating activities were $141.1 million and $61.7 million for the three months ended March 31, 2013 and 2012, respectively. This was primarily driven by collection of $226 million of accounts receivable, but was partially offset by settled payment of accrued expenses.
Accounts receivable decreased by $179.6 million, which was mainly due to the collection of accounts receivable during the first quarter of 2013. During the first quarter of 2013, the Company collected $226 million from its distributors, including $219 million of the accounts receivable outstanding at December 31, 2012. As of March 31, 2013, the amount of gross accounts receivable outstanding was $123.0 million, of which $26.2 million was past the Company's six-month credit period. Yongye recorded an allowance for doubtful receivables in the amount of $9.1 million as of March 31, 2013, taking into account current market conditions, customers' financial condition, the accounts receivable ageing and the customers' repayment patterns. The Company continues to take measures to increase collection efforts and closely monitor its distributors' financial status.
Recent DevelopmentsExpansion of Branded Retailer Network
The Company continued the expansion of its branded retailers from 35,058 as of December 31, 2012 to 35,246 as of March 31, 2013. The majority of the Company's newly recruited branded retailers are located in Hebei, Henan, Inner Mongolia, and Shaanxi provinces. The Company remains focused on expanding its distribution networks and deepening its penetration in its markets.
Update on NASDAQ Trading Halt
As the Company previously announced on April 1, 2013 as part of its fourth quarter and full year 2012 earnings announcement, on March 26, 2013, the Company
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Related biology technology :1
|SOURCE Yongye International, Inc.|
Copyright©2012 PR Newswire.
All rights reserved
. Yongye International to Report First Quarter 2013 Financial Results on May 10, 20132
. Yongye International Announces Second Quarter 2012 Financial Results3
. Yongye International to Report Second Quarter 2012 Financial Results on August 9, 20124
. Dr. Szczepan Baran will be Presenting at the International Microsurgical Simulation Society at Columbia University in New York5
. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 20136
. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"7
. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells8
. Danai Brooks Joins Dyadic International as Chief Operating Officer9
. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy10
. PAREXEL International Reports Third Quarter Fiscal Year 2013 Results11
. GeneCell International Gives Back to the Community by Participating in Local Elementary School’s Career Day